CJC-1295 (No DAC)
Growth hormone releasing hormone analog studied for pulsatile GH release.
Testing & quality
Every batch is supplier-tested for identity and purity and randomly verified by independent third-party HPLC and mass spectrometry.
Compound classification
Synthetic 30-amino-acid GHRH analog (Mod GRF 1-29) without the Drug Affinity Complex (DAC).
Mechanism studied in the literature
Binds GHRH receptors on pituitary somatotrophs; studied for short-acting pulsatile GH release in preclinical models, frequently paired with GHRPs in receptor research.
Research areas
- GHRH receptor pharmacology
- Pulsatile somatotroph signaling research
- GH/IGF-1 axis preclinical models
- Receptor desensitization studies
Storage
Lyophilized: -20°C, protected from light. Reconstituted: 2-8°C, use within 28 days.
Reconstitution (laboratory)
Reconstitute with bacteriostatic or sterile water for injection (USP grade).
Related research peptides
Ipamorelin
Selective GHRP studied for GH secretion without significant cortisol or prolactin impact.
GHRP-6
Growth hormone releasing peptide studied for GH secretion and appetite research.
Tesamorelin
GHRH analog researched for visceral adiposity and lipid metabolism.
Kisspeptin
Hypothalamic peptide studied for GnRH regulation and reproductive endocrinology.